يعرض 1 - 10 نتائج من 763 نتيجة بحث عن '"DY Oh"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1

    المصدر: The Lancet. Oncology. 20(12)

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
    دورية أكاديمية

    المؤلفون: Hwang JM; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea., Lee WJ; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea., Jo JH; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea., Uwamahoro C; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea., Jang SI; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea., Jung EJ; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea., Bae JW; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea., Kim DH; Department of Animal Science, Chonnam National University, Gwangju 61186, Republic of Korea., Yi JK; School of Animal Life Convergence Science, Hankyong National University, Anseong 17579, Republic of Korea., Ha JJ; Gyeongbuk Livestock Research Institute, Yeongju 36052, Republic of Korea., Oh DY; Gyeongbuk Livestock Research Institute, Yeongju 36052, Republic of Korea., Kwon WS; Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Republic of Korea; Research Institute for Innovative Animal Science, Kyungpook National University, Sangju 37224, Republic of Korea. Electronic address: wskwon@knu.ac.kr.

    المصدر: Reproductive toxicology (Elmsford, N.Y.) [Reprod Toxicol] 2024 Jul 06; Vol. 128, pp. 108659. Date of Electronic Publication: 2024 Jul 06.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Pergamon In Cooperation With The Reproductive Toxicology Center Country of Publication: United States NLM ID: 8803591 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-1708 (Electronic) Linking ISSN: 08906238 NLM ISO Abbreviation: Reprod Toxicol Subsets: MEDLINE

  9. 9
    دورية أكاديمية

    المؤلفون: Singh S; University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. Electronic address: simron.singh@sunnybrook.ca., Halperin D; MD Anderson Cancer Center, Houston, TX, USA., Myrehaug S; University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; National Center for Tumor Diseases (NCT), NCT West, Heidelberg, Germany., Pavel M; Department of Medicine 1, Uniklinikum Erlangen, and Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Kunz PL; Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT, USA., Chasen B; MD Anderson Cancer Center, Houston, TX, USA., Tafuto S; Sarcoma and Rare Tumors Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, Naples, Italy., Lastoria S; Division of Nuclear Medicine, Istituto Nazionale Tumori IRCCS, Fondazione G Pascale, Naples, Italy., Capdevila J; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., García-Burillo A; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea., Yoo C; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Halfdanarson TR; Mayo Clinic, Rochester, MN, USA., Falk S; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Folitar I; Novartis Pharma AG, Basel, Switzerland., Zhang Y; Novartis Pharmaceuticals Corp, East Hanover, NJ, USA., Aimone P; Novartis Pharma AG, Basel, Switzerland., de Herder WW; Erasmus MC and Erasmus MC Cancer Institute, Rotterdam, Netherlands., Ferone D; Endocrinology, IRCCS Policlinico San Martino and DiMI, University of Genova, Genoa, Italy.

    مؤلفون مشاركون: all the NETTER-2 Trial Investigators

    المصدر: Lancet (London, England) [Lancet] 2024 Jun 29; Vol. 403 (10446), pp. 2807-2817. Date of Electronic Publication: 2024 Jun 05.

    نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

    بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

    SCR Disease Name: Gastro-enteropancreatic neuroendocrine tumor

  10. 10
    دورية أكاديمية

    المؤلفون: Goyal L; Department of Medicine, Stanford University School of Medicine, & the Stanford Cancer Center, Palo Alto, CA, USA., Meric-Bernstam F; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hollebecque A; Drug Development Department, Gustave Roussy, Villejuif, France., Valle JW; Cholangiocarcinoma Foundation, Herriman, UT, USA.; Division of Cancer Sciences, University of Manchester, Manchester, UK., Morizane C; National Cancer Center Hospital, Tokyo, Japan., Karasic TB; Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Abrams TA; Mass General Cancer Center, Harvard Medical School, & Dana-Farber Cancer Institute, Boston, MA, USA., Furuse J; Kanagawa Cancer Center, Yokohama, Japan., Kelley RK; University of California, San Francisco, San Francisco, CA, USA., Cassier PA; Centre Léon Bérard, Lyon, France., Klümpen HJ; Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Chang HM; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Tabernero J; Vall d'Hebron Hospital Campus & Vall d'Hebron Institute of Oncology, University of Vic-Central University of Catalonia, Baselga Oncologic Institute, Hospital Quiron, Barcelona, Spain., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea., Mahipal A; Mayo Clinic, Rochester, MN, USA., Moehler M; University Medical Center of Johannes Gutenberg University, Mainz, Germany., Komatsu Y; Hokkaido University Hospital Cancer Center, Sapporo, Japan., Ahn DH; Mayo Clinic, Phoenix, AZ, USA., Epstein RS; Epstein Health, Woodcliff Lake, NJ, USA., Halim AB; Taiho Oncology, Inc., Princeton, NJ, USA., Wacheck V; Taiho Oncology, Inc., Princeton, NJ, USA., He Y; Taiho Oncology, Inc., Princeton, NJ, USA., Liu M; Taiho Oncology, Inc., Princeton, NJ, USA., Benhadji KA; Taiho Oncology, Inc., Princeton, NJ, USA., Bridgewater JA; University College London Cancer Institute, London, UK.

    مؤلفون مشاركون: FOENIX-CCA2 Study Investigators

    المصدر: Future oncology (London, England) [Future Oncol] 2024 Jun 17, pp. 1-12. Date of Electronic Publication: 2024 Jun 17.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE